Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

Autor: Anywaine, Zacchaeus1 (AUTHOR), Barry, Houreratou2 (AUTHOR), Anzala, Omu3 (AUTHOR), Mutua, Gaudensia3 (AUTHOR), Sirima, Sodiomon B.4 (AUTHOR), Eholie, Serge5 (AUTHOR), Kibuuka, Hannah6 (AUTHOR), Bétard, Christine7 (AUTHOR), Richert, Laura7,8 (AUTHOR), Lacabaratz, Christine8,9 (AUTHOR), McElrath, M. Juliana10 (AUTHOR), De Rosa, Stephen C.10 (AUTHOR), Cohen, Kristen W.10 (AUTHOR), Shukarev, Georgi11 (AUTHOR), Katwere, Michael11 (AUTHOR), Robinson, Cynthia11 (AUTHOR), Gaddah, Auguste12 (AUTHOR), Heerwegh, Dirk12 (AUTHOR), Bockstal, Viki11 (AUTHOR), Luhn, Kerstin11 (AUTHOR)
Zdroj: PLoS Medicine. 1/11/2022, Vol. 18 Issue 1, p1-18. 18p. 1 Diagram, 1 Chart, 2 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje